Team:Heidelberg/Sponsors

From 2009.igem.org

(Difference between revisions)
 
(46 intermediate revisions not shown)
Line 2: Line 2:
{{Template_HD_3}}
{{Template_HD_3}}
-
<html><body id="sponsors">
+
<html><body id="sponsors" onload="setPageSize()">
<style type="text/css">
<style type="text/css">
-
 
+
#news {min-height: 2000px;}
-
#news {min-height: 2200px;}
+
h2 {padding: 10px 20px;
h2 {padding: 10px 20px;
                         font-size: 18px;
                         font-size: 18px;
Line 34: Line 33:
                         border: 2px solid #FFF;  
                         border: 2px solid #FFF;  
                         }
                         }
-
#super_main_wrapper {
+
 
-
                        position:absolute; left:0px; top:227px;
+
-
margin-bottom: 30px;
+
-
width: 975px;
+
-
align: center;
+
-
background-color: #ede8e2;
+
-
                }
+
-
                #super_main_wrapper * img, #super_main_wrapper * * img {border-color: #FFF;
+
-
border-style:solid;
+
-
text-align:center;}
+
-
                #SubWrapper {width: 647px;
+
-
                        float: left;
+
-
                        margin-left: 3px;
+
-
                        margin-top: 3px;
+
-
                        background-color: #ede8e2;}
+
-
                #SubWrapper * p, #SubWrapper p {padding: 0 20px;
+
-
                        text-align: justify;
+
-
                        font-size: 12px;}
+
-
                #SubWrapper * h3 ,#SubWrapper * ul, #SubWrapper h3, #SubWrapper ul{padding: 10px 20px;
+
-
                        font-size: 18px;}
+
-
                #news {width:320px;
+
-
                        margin-top: 3px;
+
-
                        float: left;
+
-
                        background-color: #d8d5d0;}
+
-
              #news p {padding: 0 20px;
+
-
                        text-align: justify;
+
-
                        font-size: 12px;}
+
-
                #news h3 {padding: 10px 20px;
+
-
                        font-size: 18px;}
+
-
              .clear {clear:both;}
+
</style>
</style>
      
      
<div id="super_main_wrapper">
<div id="super_main_wrapper">
<div id="SubWrapper">   
<div id="SubWrapper">   
 +
<a name="top"></a>
<h2>Team-Sponsors</h2>
<h2>Team-Sponsors</h2>
<h4>Platinum Level</h4>
<h4>Platinum Level</h4>
-
<div class="gallery">
+
<div class="gallery" id="ktf">
<a href="http://www.klaus-tschira-stiftung.de/english/index.html"><h3>Klaus Tschira Foundation </h3></a>
<a href="http://www.klaus-tschira-stiftung.de/english/index.html"><h3>Klaus Tschira Foundation </h3></a>
<p> Physicist Dr. h.c. Klaus Tschira established the Klaus Tschira Foundation in 1995 as a not-for-profit organization designed to support research in informatics, the natural sciences, and mathematics, as well as promotion of public understanding in these sciences. Klaus Tschira’s commitment to this objective was honored in 1999 with the „Deutscher Stifterpreis” by the National Association of German Foundations. The home of the Foundation is the Villa Bosch in Heidelberg, the former residence of Nobel Prize laureate for chemistry Carl Bosch (1874–1940). Klaus Tschira is a co-founder of the SAP AG in Walldorf, one of the world’s leading companies in the software industry. After many years on the board of directors, Klaus Tschira is now a member of the company’s supervisory board.</p>
<p> Physicist Dr. h.c. Klaus Tschira established the Klaus Tschira Foundation in 1995 as a not-for-profit organization designed to support research in informatics, the natural sciences, and mathematics, as well as promotion of public understanding in these sciences. Klaus Tschira’s commitment to this objective was honored in 1999 with the „Deutscher Stifterpreis” by the National Association of German Foundations. The home of the Foundation is the Villa Bosch in Heidelberg, the former residence of Nobel Prize laureate for chemistry Carl Bosch (1874–1940). Klaus Tschira is a co-founder of the SAP AG in Walldorf, one of the world’s leading companies in the software industry. After many years on the board of directors, Klaus Tschira is now a member of the company’s supervisory board.</p>
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="isilon">
<a href="http://www.isilon.com/"><h3>Isilon </h3></a>
<a href="http://www.isilon.com/"><h3>Isilon </h3></a>
<p>Powering Life Science &amp; Bioinformatics Workflows</p>
<p>Powering Life Science &amp; Bioinformatics Workflows</p>
Line 82: Line 53:
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="lup">
<a href="http://www.lpsp.de/werbeagentur/"><h3>LANGE + PFLANZ </h3></a>
<a href="http://www.lpsp.de/werbeagentur/"><h3>LANGE + PFLANZ </h3></a>
 +
<p> Lange + Pflanz advertising agency Gmbh has been a specialist for Marketing and Design since 1992. Our focus covers the  fields of financial , corporate and strategic communication. As an owner-operated communication company we offer individual and enduring communication solutions for variable media platforms.</p>
 +
<p> Die LANGE + PFLANZ Werbeagentur GmbH ist seit 1992 Spezialist für Marketing + Design. Unsere Schwerpunkte liegen in den Bereichen Finanzkommunikation, Unternehmenskommunikation und Strategische Kommunikation. Als inhabergeführte Kommunikationsagentur bieten wir individuelle und nachhaltige Kommunikationslösungen auf unterschiedlichen medialen Plattformen. </p>
<p> Die LANGE + PFLANZ Werbeagentur GmbH ist seit 1992 Spezialist für Marketing + Design. Unsere Schwerpunkte liegen in den Bereichen Finanzkommunikation, Unternehmenskommunikation und Strategische Kommunikation. Als inhabergeführte Kommunikationsagentur bieten wir individuelle und nachhaltige Kommunikationslösungen auf unterschiedlichen medialen Plattformen. </p>
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="ss">
<a href="http://www.stw.de/"><h3>Steinbeis Stiftung </h3></a>
<a href="http://www.stw.de/"><h3>Steinbeis Stiftung </h3></a>
 +
<p> Using its network Steinbeis is activ in transfer of knowledge and technology. The foundation for todays worldwide activity was already laid in the 19th century by its eponym Ferdinand von Steinbeis: His commitment as an economic patron was appreciated by entrepreneurs with financial shares. Those first contributions enabled the establishment of the first Steinbeis-Foundation in 1868 advancing the industrial eduction of adolescent people.</p>
 +
<p> Steinbeis ist heute mit seinem Netzwerk weltweit im Wissens- und Technologietransfer aktiv. Den Grundstein dafür legte der Namensgeber Ferdinand von Steinbeis schon im 19. Jahrhundert: Sein Engagement als Wirtschaftsförderer dankten ihm Unternehmer mit einem finanziellen Beitrag, der die Gründung der ersten Steinbeis-Stiftung 1868 zur Förderung der gewerblichen Ausbildung von Jugendlichen möglich machte. </p>
<p> Steinbeis ist heute mit seinem Netzwerk weltweit im Wissens- und Technologietransfer aktiv. Den Grundstein dafür legte der Namensgeber Ferdinand von Steinbeis schon im 19. Jahrhundert: Sein Engagement als Wirtschaftsförderer dankten ihm Unternehmer mit einem finanziellen Beitrag, der die Gründung der ersten Steinbeis-Stiftung 1868 zur Förderung der gewerblichen Ausbildung von Jugendlichen möglich machte. </p>
</div>
</div>
-
<h4>Gold Level</h4>
+
<h4>Silver Level</h4>
-
<div class="gallery">
+
<div class="gallery" id="chroma">
<a href="http://www.chroma.com/"><h3>Chroma </h3></a>
<a href="http://www.chroma.com/"><h3>Chroma </h3></a>
<p> Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pass filters, as well as beamsplitters, dichroic mirrors and laser rejection filters. We specialize in precision spectral control, including extra high signal-to-noise ratio filters and those with rapid cut-on and cut-off profiles. The manufacturing process involves precisely depositing, in a vacuum, extremely thin layers of two or more materials on a glass or similarly transparent substrate. </p>
<p> Chroma Technology Corp. is a manufacturer of interference filters for the ultra-violet, visible and near-infrared portions of the spectrum, including bandpass, multiple bandpass, and long and short pass filters, as well as beamsplitters, dichroic mirrors and laser rejection filters. We specialize in precision spectral control, including extra high signal-to-noise ratio filters and those with rapid cut-on and cut-off profiles. The manufacturing process involves precisely depositing, in a vacuum, extremely thin layers of two or more materials on a glass or similarly transparent substrate. </p>
 +
</div>
 +
 +
<div class="gallery" >
 +
<a href="http://www.beckman.com/Default.asp?bhfv=2"><h3>Beckman Coulter</h3></a>
 +
<p> Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum—from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing—Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world.</p>
</div>
</div>
<h4>Bronze Level</h4>
<h4>Bronze Level</h4>
-
<div class="gallery">
+
<div class="gallery" id="graffinity">
<a href="http://www.graffinity.com/"><h3>Graffinity </h3></a>
<a href="http://www.graffinity.com/"><h3>Graffinity </h3></a>
<p> Graffinity is the premier partner for fragment based drug discovery and lead development of small molecule pharmaceuticals. Graffinity has built a unique approach which includes chemical microarrays, fragment screening, SPR label-free imaging of protein-ligand interactions, computational chemistry and lead discovery. The technology platform offers a new drug discovery paradigm for the rapid conversion of genomic information into novel, high quality leads and drug candidates.  
<p> Graffinity is the premier partner for fragment based drug discovery and lead development of small molecule pharmaceuticals. Graffinity has built a unique approach which includes chemical microarrays, fragment screening, SPR label-free imaging of protein-ligand interactions, computational chemistry and lead discovery. The technology platform offers a new drug discovery paradigm for the rapid conversion of genomic information into novel, high quality leads and drug candidates.  
Line 106: Line 86:
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="amnis">
<a href="http://www.amnis.com/"><h3>Amnis</h3></a>
<a href="http://www.amnis.com/"><h3>Amnis</h3></a>
<p> Amnis designs, manufactures and markets leading cell imaging instrumentation for the research and clinical markets. The Company’s flagship product is the ImageStream system, which combines the speed and sensitivity of flow cytometry with the power of high resolution digital microscopy. As the only technology capable of imaging cells at high speed directly in bodily fluids, ImageStream enables unique, non-invasive diagnostic applications. These applications include residual disease detection via high throughput FISH, circulating endothelial cell and tumor cell analysis, and advanced automated hematology based on multi-color phenotyping combined with histochemical staining. </p>
<p> Amnis designs, manufactures and markets leading cell imaging instrumentation for the research and clinical markets. The Company’s flagship product is the ImageStream system, which combines the speed and sensitivity of flow cytometry with the power of high resolution digital microscopy. As the only technology capable of imaging cells at high speed directly in bodily fluids, ImageStream enables unique, non-invasive diagnostic applications. These applications include residual disease detection via high throughput FISH, circulating endothelial cell and tumor cell analysis, and advanced automated hematology based on multi-color phenotyping combined with histochemical staining. </p>
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="sa">
<a href="http://en.sanofi-aventis.com/"><h3>Sanofi Aventis</h3></a>
<a href="http://en.sanofi-aventis.com/"><h3>Sanofi Aventis</h3></a>
<p> Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a worldwide presence. Sanofi-aventis products and services are centered on patients. Our ambition: to become a diversified global healthcare leader.</p>
<p> Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a worldwide presence. Sanofi-aventis products and services are centered on patients. Our ambition: to become a diversified global healthcare leader.</p>
 +
</div>
 +
 +
<div class="gallery" id="pk">
 +
<a href="http://www.pianohaus-keienburg.de/"><h3>Pianohaus Keienburg</h3></a>
 +
<p> Who could say to understand the brilliance of music? In fact it is as complex and phenomenal as life! Denis Noble (Oxford) has written a whole book, The Music of Life, about this similarity. And with systems biology a whole new discipline has been dedicated to the harmony of biological parts. As instrument builders have crafted for centuries filigree mechanics, iGEM will be the instrument to play the artistic notes of biology. The Pianohaus Keienburg is therefore a welcome companion on our virtuosic tour through the world of synthetic biology. And besides, did you know that also Albert Einstein was an apprehended violinist and Heisenberg a recognized pianist? They were! </p>
</div>
</div>
<h4>Academic Sponsors</h4>
<h4>Academic Sponsors</h4>
-
<div class="gallery">
+
<div class="gallery" id="uni">
<a href="http://www.uni-heidelberg.de/index_e.html"><h3> University of Heidelberg </h3></a>
<a href="http://www.uni-heidelberg.de/index_e.html"><h3> University of Heidelberg </h3></a>
<p>The future since 1386<br>
<p>The future since 1386<br>
Line 123: Line 108:
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="dkfz">
<a href="http://www.dkfz.de/index.html"><h3>German Cancer Research Center </h3></a>
<a href="http://www.dkfz.de/index.html"><h3>German Cancer Research Center </h3></a>
<p> The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is the largest biomedical research institute in Germany and is a member of the Helmholtz Association of National Research Centers. More than 2,000 staff members, including 850 scientists, are investigating the mechanisms of cancer and are working to identify cancer risk factors. They provide the foundations for developing novel approaches in the prevention, diagnosis, and treatment of cancer. In addition, the staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public.</p>
<p> The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is the largest biomedical research institute in Germany and is a member of the Helmholtz Association of National Research Centers. More than 2,000 staff members, including 850 scientists, are investigating the mechanisms of cancer and are working to identify cancer risk factors. They provide the foundations for developing novel approaches in the prevention, diagnosis, and treatment of cancer. In addition, the staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public.</p>
</div>
</div>
-
<div class="gallery">
+
<div class="gallery" id="bio">
<a href="http://www.bioquant.uni-hd.de/"><h3>Bioquant </h3></a>
<a href="http://www.bioquant.uni-hd.de/"><h3>Bioquant </h3></a>
<p> In addition to the experimental acquisition of biological data and their analysis with bio-statistical and bio-computational methods, the modelling and simulation of these processes as well as their validation have become more important than ever before. For small systems such as single molecules and small complexes, molecular models have already provided significant insights leading not only to a better understanding of interactions, but also to the rational design of new drugs. For more complex systems (large molecular complexes, cells, organs and populations), such analysis is only preliminary. On this basis, the University of Heidelberg has established the research network for the "Quantitative Analysis of Molecular and Cellular Biological Systems (BIOQUANT)" which integrates research groups from different disciplines and help them to focus on these research tasks.</p>
<p> In addition to the experimental acquisition of biological data and their analysis with bio-statistical and bio-computational methods, the modelling and simulation of these processes as well as their validation have become more important than ever before. For small systems such as single molecules and small complexes, molecular models have already provided significant insights leading not only to a better understanding of interactions, but also to the rational design of new drugs. For more complex systems (large molecular complexes, cells, organs and populations), such analysis is only preliminary. On this basis, the University of Heidelberg has established the research network for the "Quantitative Analysis of Molecular and Cellular Biological Systems (BIOQUANT)" which integrates research groups from different disciplines and help them to focus on these research tasks.</p>
</div>
</div>
-
 
+
<a style="padding: 10px 15px;" href="#top">Go to Top</a>
</div> <!-- end SubWrapper -->
</div> <!-- end SubWrapper -->
<div id="news">  
<div id="news">  
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 120px;">
+
<div class="sponsors_img" style="margin-top: 10em;">
<a href="http://www.klaus-tschira-stiftung.de/english/index.html"><img src="https://static.igem.org/mediawiki/2009/e/ee/HD09_kts-logo.jpg"/></a>
<a href="http://www.klaus-tschira-stiftung.de/english/index.html"><img src="https://static.igem.org/mediawiki/2009/e/ee/HD09_kts-logo.jpg"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 95px;">
+
<div class="sponsors_img" style="margin-top: 7.9em;">
<a href="http://www.isilon.com/http://www.isilon.com/"><img src="https://static.igem.org/mediawiki/2009/3/39/Isilonsys_logo.gif"/></a>
<a href="http://www.isilon.com/http://www.isilon.com/"><img src="https://static.igem.org/mediawiki/2009/3/39/Isilonsys_logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 110px;">
+
<div class="sponsors_img" style="margin-top: 9.6em;">
<a href="http://www.lpsp.de/werbeagentur/"><img src="https://static.igem.org/mediawiki/2009/7/7d/150px-HD09_Lange_pflanz.gif"/></a>
<a href="http://www.lpsp.de/werbeagentur/"><img src="https://static.igem.org/mediawiki/2009/7/7d/150px-HD09_Lange_pflanz.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 70px;">
+
<div class="sponsors_img" style="margin-top: 15em;">
<a href="http://www.stw.de/"><img src="https://static.igem.org/mediawiki/2009/6/6c/Stw_logo.gif"/></a>
<a href="http://www.stw.de/"><img src="https://static.igem.org/mediawiki/2009/6/6c/Stw_logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 80px;">
+
<div class="sponsors_img" style="margin-top: 11em;">
<a href="http://www.chroma.com/"><img src="https://static.igem.org/mediawiki/2009/8/8b/200px_Chroma-Logo.gif"/></a>
<a href="http://www.chroma.com/"><img src="https://static.igem.org/mediawiki/2009/8/8b/200px_Chroma-Logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 70px;">
+
<div class="sponsors_img" style="margin-top: 5.5em;">
 +
<a href="http://www.beckman.com/Default.asp?bhfv=2"><img src="https://static.igem.org/mediawiki/2009/d/d5/200px-BC_logo.jpg"/></a>
 +
</div>
 +
</center>
 +
<center>
 +
<div class="sponsors_img" style="margin-top: 6.6em;">
<a href="http://www.graffinity.com/"><img src="https://static.igem.org/mediawiki/2009/7/70/180px_Graffinity_logo.gif"/></a>
<a href="http://www.graffinity.com/"><img src="https://static.igem.org/mediawiki/2009/7/70/180px_Graffinity_logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 60px;">
+
<div class="sponsors_img" style="margin-top: 6em">
<a href="http://www.amnis.com/"><img src="https://static.igem.org/mediawiki/2009/6/6c/Amnis_logo.jpg"/></a>
<a href="http://www.amnis.com/"><img src="https://static.igem.org/mediawiki/2009/6/6c/Amnis_logo.jpg"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 60px;">
+
<div class="sponsors_img" style="margin-top: 4.8em;">
<a href="http://en.sanofi-aventis.com/"><img src="https://static.igem.org/mediawiki/2009/4/4c/Sanofi-Aventis-logo.gif"/></a>
<a href="http://en.sanofi-aventis.com/"><img src="https://static.igem.org/mediawiki/2009/4/4c/Sanofi-Aventis-logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 10px;">
+
<div class="sponsors_img" style="margin-top: 2.5em;">
 +
<a href="http://www.pianohaus-keienburg.de/"><img src="https://static.igem.org/mediawiki/2009/c/ca/Pianohauskeienburg.png"/></a>
 +
</div>
 +
</center>
 +
<center>
 +
<div class="sponsors_img" style="margin-top: 2.5em;">
<a href="http://www.uni-heidelberg.de/index_e.html"><img src="https://static.igem.org/mediawiki/2009/4/47/Heidelberg_Uni_Logo.gif"/></a>
<a href="http://www.uni-heidelberg.de/index_e.html"><img src="https://static.igem.org/mediawiki/2009/4/47/Heidelberg_Uni_Logo.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 10px;">
+
<div class="sponsors_img" style="margin-top: 4.1em;">
<a href="http://www.dkfz.de/index.html"><img src="https://static.igem.org/mediawiki/2009/5/5d/220px-Dkfz.gif"/></a>
<a href="http://www.dkfz.de/index.html"><img src="https://static.igem.org/mediawiki/2009/5/5d/220px-Dkfz.gif"/></a>
</div>
</div>
</center>
</center>
<center>
<center>
-
<div class="sponsors_img" style="margin-top: 100px;">
+
<div class="sponsors_img" style="margin-top: 5em;">
<a href="http://www.bioquant.uni-hd.de/"><img src="https://static.igem.org/mediawiki/2009/0/09/BioQuant_Logo.png"/></a>
<a href="http://www.bioquant.uni-hd.de/"><img src="https://static.igem.org/mediawiki/2009/0/09/BioQuant_Logo.png"/></a>
</div>
</div>
Line 194: Line 189:
</div>  <!-- end news -->
</div>  <!-- end news -->
</div> <!-- end Super_main_wrapper -->
</div> <!-- end Super_main_wrapper -->
 +
<script type="text/javascript">
 +
function setPageSize() {
 +
len = document.getElementById('super_main_wrapper').offsetHeight;
 +
document.getElementById('bodyContent').style.height = len + 'px';
 +
document.getElementById('news').style.height = len + 'px';
 +
}
 +
</script>
 +
</body></html>
</body></html>

Latest revision as of 21:47, 21 October 2009


Team-Sponsors

Platinum Level

Silver Level

Bronze Level

Academic Sponsors

Go to Top